09:53 AM EST - Nuvo Pharmaceuticals Inc. : And Crescita Therapeutics Inc., today announced the completion of the reorganization of Nuvo Research Inc. into two separate publicly traded companies (the Reorganization). As a result of the Reorganization, the shareholders of what was formerly Nuvo Research Inc., now own 100% of Nuvo Pharma, a revenue and EBITDA generating commercial healthcare company, and 100% of Crescita, a drug development company. Nuvo Pharmaceuticals Inc.
shares T.NRI are trading up $0.04 at $6.35.
